CTI Biopharma Corp.
Doing business as CTI Biopharma Part of Sobi, Inc.
- UEI
- H4GBVP9DGRL6
- CAGE
- 37GC6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Sobi, Inc.
Parent
S2TUAPDB2971
- CTI Biopharma Corp. H4GBVP9DGRL6
-
Sobi, Inc.
Parent
S2TUAPDB2971
- SAM.gov registration date
- Website
- sobi.com
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Zevalin imaging kit | Medical Command | $12,031 |
About CTI Biopharma Corp.
CTI Biopharma Corp., doing business as CTI Biopharma, is a for-profit organization and manufacturer of goods registered to receive awards from the U.S. federal government. The company primarily provides drugs, pharmaceuticals, and hematology-related products to federal agencies, particularly the Department of Veterans Affairs. As a biopharmaceutical company, CTI Biopharma likely focuses on developing and commercializing novel targeted therapies for blood-related cancers and other diseases. Their registration in SAM.gov, which expires on March 8, 2025, indicates their ongoing commitment to participating in federal contracting opportunities.
Based on the provided information, there is no specific data available regarding CTI Biopharma's past prime or sub federal grant awards. The summary does not include details about the company's involvement in federal grant programs, funding agencies for grant awards, or any prime or sub partners related to grant activities. Without this information, it is not possible to describe the nature of work this entity performs via grants or the types of goods and services provided through such awards.
CTI Biopharma Corp. currently holds two federal contract Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The most recent and significant IDV is a Federal Supply Schedule contract (36F79722D0202) awarded on November 1, 2022, with a ceiling value of $3,000,000 and an ultimate completion date of October 31, 2027. This multiple-award contract is for the provision of drugs, pharmaceuticals, and hematology-related products. The contract supports the VA's efforts to ensure the availability of necessary medical supplies for veterans under its care. Additionally, CTI Biopharma held an earlier interim agreement (36F79722D030E) under the same FSS Schedule 65 I B, which had a ceiling value of $25,000 and an ultimate completion date of October 31, 2022. Both contracts were awarded without any set-aside requirements, indicating full and open competition. These IDVs demonstrate CTI Biopharma's capability to supply critical pharmaceutical and hematology products to the federal government, particularly in support of veterans' healthcare needs.
Contract vehicles
Quick answers
What is CTI Biopharma Corp.'s UEI?
CTI Biopharma Corp.'s Unique Entity ID (UEI) in SAM.gov is H4GBVP9DGRL6.
What is CTI Biopharma Corp.'s CAGE code?
CTI Biopharma Corp.'s CAGE code is 37GC6.
What is CTI Biopharma Corp.'s primary NAICS code?
CTI Biopharma Corp.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Is CTI Biopharma Corp. registered in SAM.gov?
CTI Biopharma Corp.'s SAM.gov registration expired on March 8, 2025.
Who is CTI Biopharma Corp.'s parent company?
CTI Biopharma Corp. is part of Sobi, Inc.
Which contract vehicles does CTI Biopharma Corp. hold?
CTI Biopharma Corp. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is CTI Biopharma Corp.'s most recent federal award?
CTI Biopharma Corp.'s most recent federal contract award is Zevalin imaging kit (W81K0009P0318), from Medical Command, on March 12, 2009.
On GovTribe
See CTI Biopharma Corp.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors